Background: As hypertrophied myocardium predisposes the patient to decreased tolerance to ischemia and increased reperfusion injury, myocardial protection is of utmost importance in patients undergoing aortic valve replacement (AVR) for severe aortic valve stenosis (AS). Methods: Consecutive 314 patients (mean age, 62.5±10.8 years; 143 females) with severe AS undergoing isolated AVR were included. Postoperative myocardial injury (PMI) was defined as 1) maximum postoperative creatinine kinase isoenzyme MB or troponin-I levels ≥10 times of reference, 2) postoperative low cardiac output syndrome or episodes of ventricular arrhythmia, or 3) left ventricular ejection fraction of less than 55% and decrease in left ventricle (LV) ejection fraction of more than 20% of the baseline value. Results: There were 90 patients (28.7%) who developed PMI. There were five cases of early death (1.6%), all of whom had PMI. On multivariable analysis, the use of histidine-tryptophan-ketoglutarate (HTK) solution instead of blood cardioplegia (odds ratio [OR], 3.06; 95% confidence interval [CI], 1.63 to 5.77; p=0.001), greater LV mass (OR, 1.04; 95% CI, 1.01 to 1.07; p=0.007), and increased cardiac ischemic time (OR, 1.13; 95% CI, 1.05 to 1.22; p＜0.001) were independent predictors for PMI. Patients who had PMI showed significantly inferior long-term survival than those without PMI (p=0.049). Conclusion: PMI occurred in a considerable proportion of patients undergoing AVR for severe AS and was associated with poor long-term survival. HTK cardioplegia, higher LV mass, and longer cardiac ischemic duration were suggested as predictors of myocardial injury.
INTRODUCTION
Aortic valve stenosis (AS) is the most common valvular disease in the western countries, and approximately 4% of people older than 65 years are reported to have severe AS [1] . For instance, approximately 50,000 cases of AVR for severe AS are being performed annually in the United States, and these are predicted to increase by one and a half times by the year 2030 [2] . Severe AS can predispose the patient to symptoms of chest pain, syncope, and dyspnea, and the prognosis is reported to be very disappointing when these symptoms accompany. The average survival rate of these patients has been reported as only two years, and the five-year survival rate has been reported to be only 12% to 20% if the conChee-Hoon Lee, et al − 234 − dition is not treated surgically [3, 4] . Surgical aortic valve replacement (AVR) is a well-proven standard treatment of severe AS, and it has shown normalization of survival in selected populations [5] .
Despite progresses in myocardial protection strategies, cardiopulmonary bypass (CPB), surgical techniques, and perioperative management, the mortality and morbidity rates following AVR for severe AS are still not negligible with the reported mortality rates being 2.6% to 4.0% [2, 6] . The left ventricular (LV) wall is usually hypertrophied as the consequence of pressure overloading due to valvular obstruction, which develops gradually over several decades. Accordingly, delivery of a cardioplegic solution may be suboptimal in the hypertrophied LV wall, particularly in the endocardial area.
Therefore, myocardial protection of AVR for AS still remains challenging, and hence, significant postoperative myocardial injury (PMI) after AVR for severe AS is the leading cause of early death [7] .
In order to improve myocardial protection during AVR for AS, a number of studies have been conducted including those seeking ideal routes of cardioplegic solution delivery or types of cardioplegic solution, and those determining factors related to PMI [8] [9] [10] [11] [12] [13] [14] [15] . These studies, however, are limited by experimental study designs and have shown mixed results.
Therefore, there are only few comprehensive clinical studies that assess the risk factors for PMI in the setting of isolated AVR for AS with a reasonably sized cohort. Therefore, we sought to evaluate the incidence of PMI in patients undergoing isolated AVR for severe AS, and to determine the risk factors of PMI.
METHODS

1) Study population
Between August 1999 and July 2009, a total of 340 patients underwent elective isolated AVR for severe AS at the Asan Medical Center, Seoul, Korea. Patients were excluded if they had significant (＞grade 2) aortic regurgitation (n=16) or significant (＞grade 2) mitral regurgitation (n=9) because these factors can affect the analyses as confounding variables.
Finally, 314 patients formed the subject population of this study. The requirement to obtain informed consent was waived by the institutional review board due to the retrospective nature of the study.
2) Surgical techniques
Surgery involved a median sternotomy (n=304) or a limited 
4) Definition of perioperative significant myocardial injury and follow-up
Significant perioperative myocardial injury was defined if any of the following criteria were satisfied [11, 12, 15, 16] 
RESULTS
1) Baseline patient profiles
The baseline characteristics of the patients are listed in Tables 1, 2 . Patients who were affected by PMI had larger LV dimension, greater LV mass/LV mass index, and greater peak trans-aortic pressure gradient than those without PMI.
The HTK crystalloid cardioplegia was more frequently used in patients with PMI, and the routes for cardioplegic delivery were significantly different between the two groups of patients (Table 2) . 
2) Myocardial injury and early outcomes
The relationship between myocardial injury and early clinical outcomes is shown in Fig. 1 . There were 90 patients (28.7%) who developed significant myocardial injury. Of these patients, 67 had isolated cardiac enzyme elevation, 10
had LCOS with (n=8) or without (n=2) cardiac enzyme elevation, and 13 had isolated LV dysfunction on echocardiography ( Fig. 1 ).
There were five early deaths (1.6%), all of whom had myocardial injury and received HTK cardioplegia during AVR.
Of them, three patients required ECMO support postoperatively and died on ECMO. Another patient died of infective endocarditis that occurred at the implanted bio- hospitalization. On multivariable analysis, the use of the HTK solution instead of blood cardioplegics, higher LV mass, and longer aortic clamping and CPB times emerged as significant and independent risk factors of PMI (Table 3) . The 5-year survival rates were 85.0%±4.3% and 91.5%±2.6% in the patients with and without PMI, respectively (p=0.049).
3) Late outcomes
DISCUSSION
In the present study, we found that PMI occurred in a considerable proportion of patients undergoing surgical AVR for severe AS, and the overall survival was significantly affected by the occurrence of PMI. Independent determinants of PMI were longer cardiac ischemic time, greater LV mass, and the use of HTK solution instead of blood cardioplegia.
There have been several studies on the use of HTK solution for myocardial protection in cardiac surgery [15, 17] .
These studies have shown that the use of HTK solution is as safe as that of tepid blood cardioplegia with excellent early outcomes. Taking a more detailed look at these data, the present study was conducted in the setting of a mitral valve operation. The LV in the presence of severe AS is commonly hypertrophied, and therefore, the vulnerability of the myocardium against ischemia differs from that of the LV affected by the mitral valvular disease. In one study, a significantly higher rate of spontaneous ventricular fibrillation after cross-clamp removal in patients receiving HTK was observed than in those receiving blood cardioplegia [15] . Another prospective randomized study in the setting of coronary artery bypass grafting (CABG) reported that there were no significant differences in the incidence of PMI, rate of early complications, and clinical outcomes depending on the use of 'blood cardioplegia' versus 'crystalloid cardioplegia' [11] . In contrast to our study population, the cited study was performed on patients who underwent CABG. Therefore, the nature of cardioplegic delivery through the coronary vasculature might be different from that in our study population, which can explain our study result. Moreover, the mean aortic clamping time of the cited study was only 34 minutes, and this is very little time to evaluate the effect of myocardial protection.
Meanwhile, a meta-analysis was performed including randomized clinical trials that compared blood cardioplegia and crystalloid cardioplegia in heterogeneous cardiac operations [12] .
In the meta-analysis, blood cardioplegia provided significantly superior myocardial protection in terms of low incidence of the postoperative LCOS and low levels of cardiac markers.
The results of the meta-analysis are comparable to those of [18] [19] [20] . In our study, longer cardiac ischemic times were an independent risk factor for PMI on the multivariable analysis, and the results are well correlated with those of previous studies. Accordingly, the results of our study provide further support for the importance of minimizing the ischemic time. Therefore, as is well known, efforts for minimizing the myocardial ischemic time should be made during cardiac operations.
The myocardial protective effect of cardioplegia can be also influenced by the administration route [10] . In the present study, antegrade cardioplegia was more frequently used in patients who were not affected by PMI. Nevertheless, the route of cardioplegia administration was not revealed as an independent risk factor for PMI on the multivariable analysis. 
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